Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-25 @ 1:50 AM
Study NCT ID:
NCT02513095
Status:
COMPLETED
Last Update Posted:
2021-06-29
First Post:
2015-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Sponsor:
Eagle Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-21
First Submit QC Date:
None
Study First Post Date:
2015-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-29
Results First Submit QC Date:
None
Results First Post Date:
2017-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-08
Last Update Post Date:
2021-06-29
Last Update Post Date Type:
ACTUAL